Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01354223 · ClinicalTrials.gov registry record · NA

Clinical Evaluation of Stenfilcon A Soft Contact Lens When Compared to Ocufilcon B Soft Contact Lens

A NA study of Myopia, sponsored by CooperVision.

Completed
Registry status
NA
Development phase
90
Enrollment target
4
Study locations

NCT01354223 is a NA study of Myopia that has completed, run by CooperVision. The registered enrollment target is 90 participants, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (66% lower). The trial reports 4 study locations across 4 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01354223, a NA study of Myopia, has completed, sponsored by CooperVision.

COMPLETED
Registry status
NA
Development phase
90 participants
Enrollment target
4
Study locations

Study Summary

This study seeks to evaluate a new daily disposable contact lens compared to an existing daily disposable contact lens.

Conditions Studied

Myopia

Interventions

  • DEVICE stenfilcon A contact lens
  • DEVICE ocufilcon B contact lens

Study Locations (4)

California

  • Eric M. White, OD, Inc. - San Diego

Michigan

  • Vision Care Associates - East Lansing

Ohio

  • Western Reserve Vision Care - Beachwood

Tennessee

  • Primary Eyecare Group, P.C. - Brentwood

Trial Details

FieldValue
Enrollment Target 90 participants
Start Date 2010-10
Est. Completion 2011-04
Phase NA

Sponsor

CooperVision

64 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT01354223

The ClinicalTrials.gov registry entry for NCT01354223 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 267-participant average among 90 other Myopia trials with a reported enrollment target (66% lower). The listed sponsor is CooperVision, which has 64 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Myopia appearing as the primary indexed condition, and to 2 interventions - of which stenfilcon A contact lens is the first listed.

NCT01354223 reports 4 study locations spanning 4 distinct geographic areas - top geographies include California, Michigan, Ohio.

Frequently Asked Questions

What is clinical trial NCT01354223 about?

NCT01354223 is a clinical study titled "Clinical Evaluation of Stenfilcon A Soft Contact Lens When Compared to Ocufilcon B Soft Contact Lens". This study seeks to evaluate a new daily disposable contact lens compared to an existing daily disposable contact lens.

What is the current status of trial NCT01354223?

This trial is currently completed. It is a NA study. The enrollment target is 90 participants. The study started on 2010-10. Estimated completion is 2011-04.

What conditions does trial NCT01354223 study?

This clinical trial studies the following conditions: Myopia.

What interventions are being tested in trial NCT01354223?

The interventions under investigation include: stenfilcon A contact lens (DEVICE), ocufilcon B contact lens (DEVICE).

Who is sponsoring clinical trial NCT01354223?

This trial is sponsored by CooperVision, which has 64 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01354223 being conducted?

This trial has 4 study locations across California, Michigan, Ohio, Tennessee. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Myopia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Myopia

All registered trials for this condition

California

All trials with a study site in California

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.